Anthony Rodgers

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 9 papers. Top paper: “Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019”.

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

Journal of the American College of Cardiology(2020)10.1016/j.jacc.2020.11.010

N/A

14.2DataRank · unranked

11099 citations

George A. Mensah, Catherine O. Johnson, Giovanni Addolorato, Enrico Ammirati, Larry M. Baddour +65 more

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

New England Journal of Medicine(2008)10.1056/nejmoa0802987

N/A

1.3DataRank · unranked

7380 citations

Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward +20 more

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

The Lancet Diabetes & Endocrinology(2022)10.1016/s2213-8587(22)00172-3

N/A

0.701DataRank · unranked

106 citations

Zeinab Bidel, Dexter Canoy, Emma Copland, Derrick Bennett, Abbas Dehghan +95 more

Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials

Journal of the American Heart Association(2023)10.1161/jaha.122.028516

N/A

0.459DataRank · unranked

7 citations

Clare Arnott, Patrick Rockenschaub, Aletta E. Schutte, Lewis Carpenter, Muthiah Vaduganathan +13 more

Does mean systolic blood pressure less than 130 mm Hg ensure high rates of control to <140/<90 mm Hg? A cross-sectional analysis of two cohorts

BMJ Open(2025)10.1136/bmjopen-2024-090440

N/A

0.312DataRank · unranked

7 citations

Susan E Sutherland, Benjamin Martin, Benjamin Riesser, Andrew Moran, Anthony Rodgers +2 more

Heart failure with reduced ejection fraction polypill implementation strategy in Sri Lanka: design and protocol of a pilot type I hybrid randomised clinical trial

BMJ Open(2025)10.1136/bmjopen-2025-100952

N/A

0.181DataRank · unranked

2 citations

Asita de Silva, Mansi Agarwal, Saumiyah Ajanthan, Anuradha Dahanayaka, Rupasvi Dhurjati +15 more

Patient out-of-pocket costs for antihypertensive single pill combination products with cost caps

Journal of Human Hypertension(2026)10.1038/s41371-026-01177-y

N/A

0DataRank · unranked

0 citations

Kyle Tong, Joshua A. Jacobs, Brent M. Egan, Jordan B. King, Adam P. Bress +6 more

Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular disease

Nature Medicine(2024)10.1038/s41591-024-02896-w

N/A

0DataRank · unranked

45 citations

Priya M. Mehta, Tyler Jacobson, Nilay S. Shah, Jiancheng Ye, Jingjing Zhu +8 more

Female participation, and sex-specific reporting practices, in polypill randomised controlled trials in the prevention of atherosclerotic cardiovascular disease: a secondary analysis of a systematic review

European Journal of Preventive Cardiology(2024)10.1093/eurjpc/zwae307

N/A

0DataRank · unranked

0 citations

Anthony Rodgers, Anushka Patel, Robyn Norton, Mark D. Huffman, Anubha Agarwal +1 more